Invea Therapeutics Inc.

IPO (initial public offering) is the process through which a private company offers its shares to the public for the first time to raise equity capital from a broader base of public investors.

The share price is determined by one or more underwriters, depending on the size of the company. When setting the price, underwriters consider several key factors: the company's current valuation, its future growth potential, associated risks, and how they are compensated, as well as supply and demand and current public market conditions.

An underwriter tries to balance the IPO price — make it high enough to generate sufficient capital for the company, but low enough to attract investors.

Once these factors are evaluated, the company's valuation is divided by the total number of shares, resulting in the price per share.

Private companies are owned by a small circle of people: founders, executive management, and private investors. They are closed to public ownership, and their shares can't be bought on exchanges. Conversely, public companies can be owned by members of the public who purchase stocks on the market after the company's IPO.

Invea Therapeutics Inc. IPO price range is 10.00 - 12.00 USD.

Buying such stocks can be a good idea if the company has strong fundamentals and growth potential. Investors can benefit from the company's performance. Buying an IPO also allows investors to invest in a company at its initial market entry, which gives them a timing advantage before the company reaches its full potential.

However, it's crucial to bear in mind that IPOs, like any other stocks, can be highly volatile. In some instances, companies may be overhyped, leading to an inflated price that could plummet once the initial excitement wanes. Additionally, unlike established companies, IPOs often lack extensive historical data and performance records, making it challenging to fully assess their financial health and business model. This, in turn, can result in potential losses for investors.

The bottom line is that Invea Therapeutics Inc. may be a good investment, but you need to do a thorough research before making a decision.

Invea Therapeutics Inc. offers ‪3.20 M‬ shares for sale. This number is defined by the executives and the underwriter depending on how much funds the company hopes to raise and how much of the ownership it's willing to offer.

Invea Therapeutics Inc. is going to sell ‪38.40 M‬ USD worth of shares.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ Invea Therapeutics Inc. stocks will be traded under the ticker "INAI".

Like other stocks, Invea Therapeutics Inc. shares will be traded on stock exchanges, e.g., Nasdaq, NYSE, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Invea Therapeutics Inc. stocks when the company goes public right from TradingView charts — choose your broker and connect to your account.